You are here

Astellas

CV Therapeutics rejects Astellas bid as loss widens

Marketwatch

Fri, 02/20/09 - 06:04 am

CV Therapeutics

CV Therapeutics will review Astellas offer again

Forbes

Thu, 01/29/09 - 09:55 am

CV Therapeutics

Astellas turns hostile in bid to buy CV Therapeutics

Pharma Times, UK

Wed, 01/28/09 - 07:45 am

CV Therapeutics

Astellas Proposes to Acquire CV Therapeutics for $16 Per Share in Cash

Yahoo

Tue, 01/27/09 - 09:41 am

CV Therapeutics

Protopic(R) Ointment (tacrolimus monohydrate) Receives Positive Opinion for Twice-Weekly use (Maintenance Treatment) in the Treatment of Atopic Dermatitis by the European Medicines Agency

Pipeline Review

Sat, 01/24/09 - 12:49 pm

Protopic Ointment

Pages